To determine the immediate effects of bilevel non-invasive ventilation plus oxygen (NIV þ O 2 ) during exercise compared to exercise with O 2 alone in people recovering from acute on chronic hypercapnic respiratory failure (HRF), a randomised crossover study with repeated measures was performed.
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Summary
To determine the immediate effects of bilevel non-invasive ventilation plus oxygen (NIV þ O 2 ) during exercise compared to exercise with O 2 alone in people recovering from acute on chronic hypercapnic respiratory failure (HRF), a randomised crossover study with repeated measures was performed.
Eighteen participants performed six minute walk tests (6MWT) and 16 participants performed unsupported arm exercise (UAE) tests with NIV þ O 2 and with O 2 alone in random order.
Distance walked increased by a mean of 43.4 m (95% CI 14.1 to 72.8, p Z 0.006) with NIV þ O 2 compared to exercise with O 2 alone. In addition, isotime oxygen saturation increased by a mean of 5% (95% CI 2e7, p Z 0.001) and isotime dyspnoea was reduced [median 2 (interquartile range (IQR) 1e4) versus 4 (3e5), p Z 0.028] with NIV þ O 2 . A statistically significant increase was also observed in UAE endurance time with NIV þ O 2 [median 201 s (IQR 93e414) versus 157 (90e342), p Z 0.033], and isotime perceived exertion (arm muscle fatigue) was reduced by a mean of 1.0 on the Borg scale (95% CI À1.9 to À0.1, p Z 0.037) compared with O 2 alone.
Non-invasive ventilation plus O 2 during walking resulted in an immediate improvement in distance walked and oxygen saturation, and a reduction in dyspnoea compared to exercise with O 2 alone in people recovering from acute on chronic HRF. The reduction of dyspnoea during walking and arm muscle fatigue during UAE observed with NIV þ O 2 may allow patients to better tolerate exercise early in the recovery period. ª 2009 Elsevier Ltd. All rights reserved.
Introduction
Patients with chronic hypercapnic respiratory failure (HRF) have a decreased exercise capacity and reduced activity levels compared to healthy controls. 1, 2 They often report severe exertional dyspnoea 3 and have limited ventilatory reserve during exercise. 4, 5 With the development of acute on chronic HRF, ventilatory capacity decreases further. 6, 7 Consequently, severe dyspnoea 8 and unstable gas exchange may delay the onset of exercise rehabilitation and place patients at risk of further deconditioning.
Non-invasive ventilation during exercise has been shown to reduce dyspnoea in proportion to respiratory muscle unloading, 9 ,10 improve gas exchange, 11e13 and increase endurance time compared to unassisted exercise in patients with chronic HRF secondary to severe COPD 3, 11 and severe restrictive chest wall disorders.
14e16 While invasive mechanical ventilation during walking has been described in stable hospitalised ventilator-dependent patients 8, 17, 18 and during supported arm exercise (SAE) in difficult to wean patients with COPD and HRF, 19 the effect of non-invasive ventilation plus oxygen (NIV þ O 2 ) during walking or during functional (unsupported) arm exercise compared to standard therapy (exercise with O 2 alone) is unknown in patients recovering from acute on chronic HRF. If NIV þ O 2 during exercise can provide similar benefits to patients recovering from acute HRF as in stable patients with HRF, it may permit exercise rehabilitation to be commenced earlier in the hospital stay, thus reducing the risk of further deconditioning.
The aim of the present study was to determine the effects of bilevel NIV þ O 2 during ground walking and unsupported arm exercise (UAE) on exercise capacity compared to exercise with O 2 alone in people recovering from acute on chronic HRF. We hypothesised that NIV þ O 2 during exercise would reduce dyspnoea, improve oxygenation and allow patients to exercise for longer compared with O 2 alone.
Method Participants
Fourteen participants recovering from acute on chronic HRF performed a series of six minute walk tests (6MWT) and a series of UAE tests. An additional four participants performed the 6MWT only, giving a total of 18 participants who performed the series of 6MWT. An additional two participants performed UAE tests only, giving a total of 16 participants who performed the series of UAE tests. Participant characteristics are described in Table 1 . Inclusion criteria were all of the following: admitted to hospital with acute on chronic HRF (pH < 7.35, PaCO 2 > 45 mmHg, HCO 3 À > 26 mmol/L) that required ongoing treatment with NIV; history of severe chronic lung disease or severe chest wall restrictive disorder; dyspnoea as the primary symptom that limited daily activities. Bilevel NIV was commenced if the respiratory acidosis (pH < 7.35) persisted despite judicious use of supplemental O 2 therapy. Standard medical therapy was instituted in conjunction with NIV and included, but was not limited to, supplemental O 2 , bronchodilators, antibiotics, corticosteroids and diuretics where indicated. Exclusion criteria at the time of exercise testing were any of the following: unable to tolerate >1 h off NIV; arterial pH < 7.35; temperature >38 C; SpO 2 < 88% at rest with a fraction of inspired oxygen !0.5; resting systolic blood pressure <90 mmHg or >160 mmHg; resting diastolic blood pressure <60 mmHg or >100 mmHg; unstable angina or a myocardial infarct during the previous month; resting heart rate (HR) >120 beats/min; or decreased level of consciousness.
Study design and protocol
A randomised crossover study with repeated measures was performed on an ambulatory respiratory medicine ward of a large teaching hospital with a dedicated acute NIV service.
Participants were asked to perform two six minute walk tests (6MWT) and two UAE tests. In those participants who performed both 6MWT and UAE tests, the order of testing was randomised. In addition, the order of 6MWT with O 2 alone and with NIV þ O 2 was randomised, and the order of UAE with O 2 alone and with NIV þ O 2 was randomised. If a participant was unable to perform both series of 6MWT and UAE tests due to a musculoskeletal or neurological condition that affected the upper or lower limbs, the type of test the participant was able to perform was selected. The randomisation scheme was generated using a web site (http://www.Randomization.com) and test order was concealed in a sealed, opaque envelope until written consent was obtained from participants. All tests were completed within one day. Ethical approval was obtained from the Human Ethics Committee of Sydney South West Area Health Service and The University of Sydney. The study was registered as part of a larger trial with the Australian New Zealand Clinical Trials Registry (ACTRN12605000215628).
One hour prior to the two 6MWTs, a practice 6MWT was conducted with NIV þ O 2 to familiarise participants to the test 20 and to walking with NIV. Similarly, one hour prior to the two UAE tests, a practice UAE test was conducted with O 2 alone to familiarise participants to the test. Participants rested for at least one hour between each 6MWT and at least one hour between each UAE test and until SpO 2 , HR, dyspnoea and perceived exertion scores returned to baseline. Oxygen flow was delivered to ensure a resting SpO 2 of approximately 93% and was not adjusted further during exercise. Standardised encouragement was given each minute during exercise. Participants were instructed to exercise until they felt too breathless or fatigued to continue. The investigator paused the 6MWT or stopped the UAE test if SpO 2 < 75% during exercise. In addition, the UAE test was terminated if participants could not keep in time with the metronome.
Exercise tests
Six minute walk test The 6MWT was performed according to the American Thoracic Society guidelines 21 with two exceptions. Firstly, participants used a forearm support frame to enable them to walk safely and independently, and secondly, a research assistant pushed a trolley containing the bilevel machine and related equipment behind the participant during each 6MWT.
Unsupported arm exercise test
An externally paced unsupported arm exercise test as described by Takahashi and colleagues 22 was modified to measure endurance rather than peak exercise capacity. The test required the seated participant to lift a weighted dowel from waist height to increasingly higher levels on a chart. The pace of lifting was one lift every two seconds in time with a metronome. In a practice test, after five repetitions (10 s) at each level, participants progressed through the levels on the chart until they reached a level that they deemed to be a moderate workload on the rate of perceived exertion (RPE) scale (score of 3). Participants were instructed to exercise at this level for as long as possible. The same level on the chart that was achieved in the practice test was used for the two subsequent UAE tests. 23 were measured on a 0e10 category-ratio scale at baseline, every 30 s during exercise, and at end exercise. Blood pressure was measured manually at baseline and end exercise.
Non-invasive ventilation
Non-invasive ventilation was delivered using a pressure preset bilevel machine (VPAPIII STä, ResMed, Sydney, Australia) via a full face mask (Ultra-mirageä, ResMed, Sydney, Australia; or, Comfort-Fullä, Respironics, Murrysville, PA, USA). The bilevel machine was set in the spontaneous mode with an expiratory positive airway pressure (EPAP) of 4e5 cmH 2 O. Inspiratory positive airway pressure (IPAP) was set 10 cmH 2 O above EPAP and was increased at rest to a level of comfort. Exercise settings are described in Table 1 . The inspiratory trigger threshold was 4.5 L/min and maximum inspiratory flow rate was 170 L/min. The minimum rise time (time from EPAP to IPAP) of 100 ms was used. Supplemental O 2 was added via a t-piece near the air outlet of the machine. A 12-volt external battery powered the bilevel machine during walking.
Data analysis and statistics
The primary outcome measure for the 6MWT was total distance walked. Secondary outcome measures were distance and time to first rest, isotime SpO 2 and dyspnoea. Isotime was defined as the earliest time-point where the participant rested during either 6MWT. Dyspnoea scores and SpO 2 from NIV þ O 2 and O 2 tests were compared at this point in time. To detect a 48 metre change in 6MWD 24 with NIV þ O 2 , using a SD estimate of 51 m (based on data from the first 5 participants), power of 0.8, and a of 0.05, a sample of 18 participants was required. For UAE, the primary outcome measure was endurance time and secondary outcome measures were isotime SpO 2 and dyspnoea, where isotime was defined as the end point of the shorter endurance test. To detect a 30 s change in UAE endurance time with NIV þ O 2 , using a SD estimate of 39 s (based on data from the first 5 participants), power of 0.8, and a of 0.05, a sample of 16 participants was needed.
Descriptive data for continuous variables with a normal distribution are presented as mean AE standard deviation (SD), or median and interquartile range (IQR) for data that failed the Kolmogorob-Smirnov normality test. Paired t-tests, or Wilcoxon signed rank tests for non-parametric data, were conducted to determine if there was a difference between exercise with NIV þ O 2 and exercise with O 2 alone with respect to the primary and secondary outcome measures. A significance level of p < 0.05 was used for all comparisons.
Results
The median time from hospital admission to performance of the exercise tests was 4 days (IQR 2e7). All participants completed the exercise tests. Oxygen saturation fell below 75% in three participants during the 6MWT with O 2 . No adverse events occurred. Fig. 1a ). In addition, distance to first rest, time to first rest and isotime SpO 2 were increased, while isotime dyspnoea was decreased with NIV þ O 2 during walking ( Table 2 , Fig. 1b) . The primary symptom limiting walking was dyspnoea (NIV þ O 2 : n Z 14; O 2 alone: n Z 17), leg muscle fatigue (NIV þ O 2 : n Z 2; O 2 alone: n Z 0), or a combination of dyspnoea and leg muscle fatigue (NIV þ O 2 : n Z 2; O 2 alone: n Z 1). There was no effect of test order on any of the primary or secondary outcome measures.
Six minute walk test
Exercise with NIV þ O 2 significantly increased total distance walked by a mean 43.4 m (95% CI 14.1e72.8, p Z 0.006) compared to exercise with O 2 alone (Table 2,
Unsupported arm exercise
There was a statistically significant increase in UAE endurance time with NIV þ O 2 compared to exercise with O 2 alone [median 201 s (IQR 93e414) versus 157 s (90e342), p Z 0.033] ( Table 3 , Fig. 2a ). There was no difference in isotime SpO 2 or dyspnoea with NIV þ O 2 . However, isotime RPE was reduced compared to exercise with O 2 alone (Table  3 , Fig. 2b ). The primary symptom limiting UAE was arm muscle fatigue (NIV þ O 2 : n Z 15; O 2 alone: n Z 14), dyspnoea (NIV þ O 2 : n Z 1; O 2 alone: n Z 1), or a combination of arm muscle fatigue and dyspnoea (O 2 alone: n Z 1). There was no effect of test order on any of the primary or secondary outcome measures.
Discussion
The main findings of the present study were that bilevel NIV þ O 2 during ground walking increased distance walked, improved SpO 2 and reduced dyspnoea compared to exercise with O 2 alone in patients recovering from acute on chronic HRF. An improvement in UAE endurance time was also found with NIV þ O 2 compared to exercise with O 2 alone, and was associated with a reduction in arm muscle fatigue. Exercise performed several days after admission to hospital was safe and well tolerated in these patients.
Improvements in exercise capacity and dyspnoea have been observed after exercise training in patients recovering from acute respiratory failure. 8, 25 However, severe dyspnoea 8 and unstable gas exchange can delay activity and place patients at risk of further deconditioning in the early stages of recovery. The detrimental effects of prolonged bed rest on muscle strength and function are well described. 26 Currently, there are no evidence-based recommendations regarding strategies to alleviate dyspnoea and improve functional exercise performance in the early stages of recovery from acute on chronic HRF. The present study provides novel information in this area.
Effect of non-invasive ventilation plus oxygen during ground walking
The present study is the first to demonstrate the benefits of NIV during walking in patients recovering from acute on chronic HRF. Total distance walked increased by a mean of 43.4 m, and distance to first rest increased by a mean of 61.6 m with NIV þ O 2 compared to walking with O 2 alone. The minimal clinically important difference in 6MWD is not known in patients recovering from acute on chronic HRF. However, the change in 6MWD with NIV þ O 2 is comparable to the mean change in 6MWD of 48 m (95% CI 32e65) after at least four weeks of supervised outpatient pulmonary rehabilitation in patients with COPD. 24 Median time to ''first rest'' was 6 min with NIV þ O 2 compared to 3.1 min with O 2 alone, indicating that many participants completed the 6MWT with NIV þ O 2 without stopping to rest. While it is unknown whether the changes observed are clinically significant, the reduction in dyspnoea and improvement in oxygenation observed suggest that NIV þ O 2 during walking may allow patients to commence exercise earlier in the recovery phase, thus reducing the risk of deconditioning.
The mechanisms of improved walking performance with NIV þ O 2 most likely relate to the reduction in dyspnoea and improvement in SpO 2 compared to walking with O 2 alone that was observed at isotime exercise. As dyspnoea was the primary symptom that limited walking in our participants, reduction of this unpleasant symptom with NIV þ O 2 probably played a key role in allowing participants to walk further with fewer rests. In stable patients with COPD, NIV during exercise was found to reduce dyspnoea in proportion to respiratory muscle unloading. 9, 10 Similarly in patients recovering from acute on chronic HRF, NIV may have unloaded the respiratory muscles, thereby reducing dyspnoea.
Oxygen saturation was higher with NIV þ O 2 during exercise and this may have resulted in improved muscle oxygenation and contributed to the improvement in exercise performance. 27 In addition, patients with chronic HRF due to severe COPD or kyphoscoliosis can develop a combined respiratory and metabolic acidosis during exercise. 12, 13 Acute hypercapnia with a respiratory acidosis can significantly impair respiratory muscle function. 28, 29 In stable patients, NIV during exercise has been shown to reduce exercise induced hypercapnia and improve exercise performance. 12, 13 However, the advantage of NIV þ O 2 during walking over O 2 alone in preventing CO 2 retention in patients recovering from acute on chronic HRF is yet to be confirmed. Finally, EPAP may have assisted participants with severe airflow limitation and intrinsic positive end expiratory pressure (PEEP) during walking. Dynamic hyperinflation commonly occurs during ground walking in patients with severe COPD and is associated with an increase in dyspnoea in proportion to the reduction in inspiratory capacity. 30 Application of external PEEP at rest has been shown to unload the respiratory muscles in patients with COPD and acute HRF with intrinsic PEEP. 31 Whether the application of EPAP during exercise can delay the onset or extent of dynamic hyperinflation remains to be demonstrated in patients recovering from acute on chronic HRF as well as in those with stable COPD.
Effect of non-invasive ventilation plus oxygen during unsupported arm exercise While a statistically significant improvement in UAE endurance time was found with NIV þ O 2 compared to exercise with O 2 alone, examination of individual data (Fig. 2) revealed that only a few participants demonstrated a substantial increase in endurance time. This is in contrast to a previous study performed by our group in patients with Pressure support during exercise has previously been shown to improve SAE capacity in people recovering from acute on chronic HRF who were slow to wean from mechanical ventilation. 19 Due to specificity of training, UAE is preferable over SAE for functional exercise training. 32 However, UAE is more difficult to perform than SAE because during UAE, some accessory respiratory muscles have a dual task of performing the upper limb activity as well as assisting respiration. Consequently, some of the ventilatory load is shifted to the diaphragm and abdominal muscles. 33 In our participants, despite arm muscle fatigue being the primary symptom that limited UAE, severe dyspnoea (mean 4.9) was reported at isotime during exercise with O 2 alone. Non-invasive ventilation has previously been shown to unload the diaphragm during arm elevation in patients with chronic HRF. 34 The inverse relationship between respiratory muscle unloading and dyspnoea 9 has been discussed previously. We found a small non-significant reduction in isotime dyspnoea (mean 1.0) with NIV þ O 2 compared to UAE with O 2 alone. This was considerably lower than the mean reduction in isotime dyspnoea of 2.3 that was found with NIV during UAE in stable patients with chronic HRF. 16 It is possible that the level of pressure support (IPAPeEPAP) delivered in the current study was too low to sufficiently unload the respiratory muscles during UAE in the majority of participants, and therefore to significantly reduce dyspnoea and cause a substantial increase in exercise endurance time.
In the present study, isotime RPE (arm muscle fatigue) was reduced by a mean of 1.0 on the Borg scale with NIV þ O 2 during UAE which was similar to the reduction in isotime RPE observed in stable patients with chronic HRF. 16 Despite this reduction, the majority of participants eventually terminated UAE due to arm muscle fatigue whether NIV þ O 2 or O 2 alone was used. The fatigue was most likely attributable to the effect of repetitive exercise in a small muscle group. However, even a small reduction of arm muscle fatigue may enable patients recovering from acute on chronic HRF to better tolerate UAE early in the recovery period.
The use of NIV þ O 2 during exercise as part of routine clinical practice does have resource implications. Therefore, investigation of the cost-benefit relationship of such a strategy during early exercise rehabilitation in people recovering from acute on chronic HRF is warranted and should evaluate outcome measures including staff time, length of stay, functional exercise capacity, physical activity and quality of life following discharge.
Limitations
Neither participants nor investigators were blinded to NIV in this study. To minimise potential bias, standardised instructions and encouragement were given. Sham NIV was not used because an effective sham has not been identified for this population. In addition, we had to limit the number of tests performed to prevent excessive fatigue, and wanted to compare the effect of NIV þ O 2 during exercise to usual clinical practice (exercise with O 2 alone) rather than sham.
Another potential limitation was that a heterogeneous group of patients were studied. While the mechanisms that contribute to dyspnoea and exercise limitation differ between patients with severe chronic lung disease and those with severe chest wall restriction, both groups often have very limited ventilatory reserve during exercise, 4, 5 both have been shown to derive benefit from NIV during exercise when stable, 3, 11, 14, 16 and examination of individual data (Figs. 1 and 2 ) does not suggest a particular pattern of response to NIV during exercise based on diagnostic group alone. In addition, disease severity appears to be an important factor that affects the response to NIV during exercise, even within patients from the same diagnostic group. This has been demonstrated in people with stable COPD, 3,35 kyphoscoliosis 14 and with CPAP during exercise in people with cystic fibrosis, 36 where those subjects with more severe disease achieved greater improvements with NIV or CPAP during exercise than those with less severe disease. The participants included in the present study all had severe disease with a greatly reduced ventilatory capacity, and therefore presented as a group who may benefit from NIV þ O 2 during exercise.
Conclusion
Bilevel NIV þ O 2 during ground walking resulted in an immediate improvement in distance walked and SpO 2 compared to exercise with O 2 alone in people recovering from acute on chronic HRF. The combination of NIV þ O 2 reduced dyspnoea during walking and arm muscle fatigue during UAE compared to exercise with O 2 alone and therefore may assist patients to tolerate exercise rehabilitation early in the recovery phase in an attempt to avoid deconditioning.
